Medshine Discovery Inc.

Qilu Pharmaceutical Co., Ltd.

Zhejiang Ocean University

Glenfly Tech Co., Ltd.

Shanghai Zhenhua Heavy Industries Company Limited

Xiaofei Wang

Jian Li

Shuhui Chen

Kai Zhou

Fang Liu

Haiying He

Xiaolin Li

Guoping Hu

Kevin X Chen

Zhaoguo Chen

Yanxin Yu

Zheng Wang

Cheng Xie

Xingxing Wang

Boyu Hu

Huaming Wang

Xinde Chen

Linghui Wu

Dakun Qin

Lin Chen

Zongbin Li

Zhenhuang Du

Yuan Jiang

Junmei Liu

Qiaorui Wu

Guorong Wu

Hua Qin

Yuedong Zhou

Xiaojun Zhang

Xiaoyi Fang

Jiang Ying

Liangzhou Mao

Yongsheng Huang

Feifei Yang

Xuemei Chi

The present disclosure relates to an image scaling method and an apparatus thereof. The method includes: for at least one interpolation pixel in a source image, grouping at least two adjacent pixels of the interpolation pixel to obtain adjacent pixel sets; no intersection existing between the adjacent pixel sets; determining, based on position relationships between the interpolation pixel and regions formed by the adjacent pixel sets, virtual interpolation pixels corresponding to the interpolation pixel in the regions formed by the adjacent pixel sets respectively; calculating corresponding pixel sampling values of the virtual interpolation pixels in the source image according to a preset bilinear interpolation algorithm respectively; and generating theoretical pixel values corresponding to the interpolation pixel based on the pixel sampling values corresponding to the virtual interpolation pixels; the theoretical pixel values being configured to perform image scaling on the source image. The processing efficiency of the image scaling can be improved with the method.

Image scaling method and apparatus thereof

Disclosed are a series of pyridopyrimidine compounds and a use of same in the preparation of drugs associated with mTORC 1/2 dual complex inhibitors, and specifically disclosed is a use of the compounds as shown in formula (IV), tautomers thereof or pharmaceutically acceptable salts thereof in the preparation of drugs associated with mTORC 1/2 dual complex inhibitors. 

Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors

A recovery device for an unmanned underwater vehicle (UUV) includes a first recovery component arranged on an unmanned ship and a second recovery component arranged on the UUV. Two magnets are provided on an end of the first recovery component and an end of the second recovery component which are opposite to each other, respectively. A first cable of the unmanned ship is provided on an end of the first recovery component away from the magnet, and a second cable is provided on an end of the second recovery component away from the magnet. A thruster is provided on a side of the first recovery component. The UUV is recovered using the unmanned ship through the recovery components connected to the cables, which allows the locating and navigation errors to a large extent.

Recovery device and recovery method of unmanned underwater vehicles

Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to Areceptor. The R, R, R, ring A, ring B, n, and m are as defined in the specification. 

[1,2,4]triazolo[1,5-c]pyrimidine derivative as Areceptor inhibitor

Disclosed in the present disclosure are a crystal form of a dihydropyrido ring compound, and preparation method and intermediate thereof. 

Crystal form, preparation method and intermediate of dihydropyrido ring compound

Disclosed is a dihydropyrimido fused ring derivative as a HBV inhibitor, and in particular relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof. 

Dihydropyrimido fused ring derivative as HBV inhibitor

Growing community of inventors

Shanghai, China

Xiaofei Wang